News
As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...
PLAINSBORO, N.J., May 1, 2025 /PRNewswire/ -- Today, Novo Nordisk announced that CVS ... preferred GLP-1 medicine on its largest commercial template formularies. This change will be effective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback